Abstract:Abstract Background: PPARγ and FOXO1 are key regulators of transcription factors that mediate insulin sensitivity. We previously showed that a small ubiquitin-related modifier of PPARγ1 at K77 (SUMOylation) favors endothelial insulin resistance (IR) induced by high-fat/high-glucose (HF/HG) administration. However, whether and how the crosstalk between SUMOylated PPARγ1 and FOXO1 mediates the development of IR remains unclear. Here, we place emphasis on elucidating how PPARγ1-K77 SUMOylation interacts with FOXO1 and participates in the development of endothelial IR.Methods: Adenovirus or adeno-associated virus carrying a truncated PPARγ1 containing AF1 and DBD domains fused with SUMO-1 (PPARγ1[1-182 aa]-SUMO-1 fusion protein) was utilized to simulate PPARγ1-K77 SUMOylation. Furthermore, we carried out PPARγ1-K77 SUMOylation imitating-IR and worsening-IR experiments in vitro and in vivo. The vascular diastolic function and levels of p-IKK, IKK, p-PI3K, PI3K, p-Akt, Akt, p-eNOS, and eNOS were measured. To elucidate the underlying mechanism, the interaction of PPARγ1-K77 SUMOylation and FOXO1 was examined by co-immunoprecipitation. The recruitment of PPARγ1 or FOXO1 to PPRE was analyzed by chromatin immunoprecipitation, followed by measuring the PPARγ1 transcriptional activity and translocation of FOXO1.Results: Our results show that like HF/HG, PPARγ1-K77 SUMOylation imitates endothelial IR and dysfunction, presenting decreased NO levels and elevated ET-1 levels, with PI3K/Akt/eNOS pathway inhibited, and endothelium-dependent vasodilation function impaired. Moreover, combination of HF/HG and PPARγ1-K77 SUMOylation exhibits a synergistic worsening effect on endothelial IR. Mechanistically, the results reveal that PPARγ1-K77 SUMOylation readily interacts with FOXO1, and the PPRE binding site of PI3K is competitively blocked by FOXO1, which represses PPARγ1 transcriptional activity and downregulates the PI3K-Akt pathway. Inhibition of the PI3K-Akt pathway promotes the nuclear accumulation of FOXO1, which interacts with SUMOylated PPARγ1 in the nucleus, exerting a positive feedback effect on IR pathogenesis.Conclusion: These results reveal a novel association between PPARγ1-K77 SUMOylation and FOXO1, which inhibits PPARγ1 transcriptional activity and contributes to vascular endothelial IR. These findings will be beneficial for better understanding the pathogenesis of endothelial IR and providing novel pharmacological targets for diabetic angiopathy.

SUMO modification selectively regulates transcriptional activity of peroxisome-proliferator-activated receptor γ in C2C12 myotubes

Sumoylation Activates The Transcriptional Activity Of Pax-6, An Important Transcription Factor For Eye And Brain Development

Adipose Tissue-Specific PPARγ Deficiency Increases Resistance to Oxidative Stress

SUMO-specific Protease 1 Regulates Mitochondrial Biogenesis Through PGC-1α.

SUMOylation of PPARγ by Rosiglitazone Prevents LPS-Induced NCoR Degradation Mediating Down Regulation of Chemokines Expression in Renal Proximal Tubular Cells

233-LB: Role of SUMO-Specific Protease 2 (SENP2) in Modulating Brown Adipose Tissue Activity

An Essential Role of Small Ubiquitin-like Modifier (Sumo)-Specific Protease 2 in Myostatin Expression and Myogenesis*

Role of SUMO-Specific Protease 2 in Leptin-Induced Fatty Acid Metabolism in White Adipocytes

Small Ubiquitin-Like Modifier (sumo) Protein-Specific Protease 1 De-Sumoylates Sharp-1 Protein and Controls Adipocyte Differentiation

SUMO modification regulates the transcriptional activity of XBP1.

DeSUMOylation: An Important Therapeutic Target and Protein Regulatory Event.

Crosstalk between SUMOylated PPARγ1 and FOXO1 Exerts a Positive-feedback Effect on Vascular Endothelial Insulin Resistance

SUMO2 and SUMO3 transcription is differentially regulated by oxidative stress in an Sp1-dependent manner.

SENP3 is responsible for HIF-1 transactivation under mild oxidative stress via p300 de-SUMOylation.

Research progression on biologic function and effect of SUMO-specific proteinase

SUMO modification enhances p66-mediated transcriptional repression of the Mi-2/NuRD complex

Sumoylation of PPARγ Contributes to Vascular Endothelium Insulin Resistance Through Stabilizing the PPARγ–NcoR Complex

SENP3-Mediated PPARγ2 DeSUMOylation in BM-MSCs Potentiates Glucocorticoid-Induced Osteoporosis by Promoting Adipogenesis and Weakening Osteogenesis

SUMO-specific protease 2 is essential for suppression of polycomb group protein-mediated gene silencing during embryonic development.

Regulation of REGγ cellular distribution and function by SUMO modification

SENP2 Regulates MEF2A De-Sumoylation in an Activity Dependent Manner.